Comparison of the segregation of the RYR1 C1840T mutation with segregation of the caffeine halothane contracture test results for malignant hyperthermia susceptibility in a large Manitoba mennonite family

被引:30
|
作者
Serfas, KD
Bose, D
Patel, L
Wrogemann, K
Phillips, MS
MacLennan, DH
Greenerg, CR
机构
[1] Department of Human Genetics, University of Manitoba, Winnipeg, Man. R3E 0W3
关键词
Anesthetics; volatile:; halothane; Caffeine/halothane contracture test; Calcium release channel (ryanodine receptor); Malignant hyperthermia susceptibility testing; Mutation analysis; Neuromuscular blocking agent: succinylcholine; RYR1 C1840T mutation testing;
D O I
10.1097/00000542-199602000-00009
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Malignant hyperthermia (MH) is an important cause of anesthesia-induced death. Malignant hyperthermia susceptibility is diagnosed using the in vitro caffeine/halothane contracture test (CHCT) in fresh muscle biopsy specimens. The CHCT test is highly invasive, expensive, and tacks 100% specificity. Genetic and biochemical evidence provide strong support for the view that the substitution of cysteine for arginine 614 (Arg614Cys) in the human ryanodine receptor gene is one of several mutations that are likely to cause human MH. DNA testing was compared with CHCT as a means of predicting MH susceptibility in a large MH family in which the Arg614Cys mutation was detected. Methods: A comparison of CHCT and DNA-based diagnosis was conducted in a large Manitoba Mennonite MH kindred identified by an index patient who died at age 45 yr of an MH crisis after general anesthesia. The presence of the Arg614Cys mutation was detected through a combination of polymerase chain reaction and restriction endonuclease digestion. Blood samples for DNA analysis were obtained from 68 family members, including 19 who had undergone muscle biopsies and 1 who had a documented crisis but did not undergo biopsy. Family members were classified as MH-susceptible or MH-normal on the basis of the CHCT. Results: Twenty-two persons were found to be heterozygous for the Arg614Cys mutation. Five of these persons had prior positive CHCT results and one had an MH crisis but did not undergo biopsy. On DNA testing, 44 persons were found to be homozygous for the normal allele. Of these, ten had been classified as MH-normal and five as MH-susceptible on the basis of the CHCT. On reevaluation of the data obtained in our earlier CHCT diagnoses, we found that the condition of the muscle was poor, with no twitch, for three of five individuals homozygous for the normal allele but originally classified as MH- susceptible and for one who was homozygous for the normal allele and originally classified as MH-normal. Caffeine/halothane contracture test results for these four persons were considered invalid. The twitch response was good for the two remaining persons who were homozygous for the normal allele but classified as MH-susceptible, because contracture was observed with appropriately low levels of both caffeine and halothane. Conclusions: An absolute correlation between DNA test results and CHCT assignment could not be made in this kindred. Possible explanations for discordance are that the Arg614Cys mutation is not linked to MH, that a second MH mutation is segregating in the family, or that there are errors in the CHCT. Because there is strong evidence supporting the causal nature of the Arg614Cys mutation, the discordant persons are not closely related within the pedigree as they would be if a second MH mutation were segregating, and the CHCT is not 10096 accurate, we propose that the observed discordance between DNA test results and CHCT assignment in this kindred results from two false-positive diagnoses by the CHCT.
引用
收藏
页码:A29 / A30
页数:2
相关论文
共 9 条
  • [1] Discordance between malignant hyperthermia susceptibility and RYR1 mutation C1840T in two Scandinavian MH families exhibiting this mutation
    Fagerlund, TH
    Ording, H
    Bendixen, D
    Islander, G
    Twetman, ER
    Berg, K
    CLINICAL GENETICS, 1997, 52 (06) : 416 - 421
  • [2] NO-C1840 TO T-MUTATION IN RYR1 IN MALIGNANT HYPERTHERMIA
    HALLCURRAN, JL
    STEWART, AD
    BALL, SP
    HALSALL, JP
    HOPKINS, PM
    ELLIS, FR
    HUMAN MUTATION, 1993, 2 (04) : 230 - 230
  • [3] Evidence for a spontaneous C1840-T mutation in the RYR1 gene after DNA fingerprinting in a malignant hyperthermia susceptible family
    Markus Steinfath
    Peter Seranski
    Surjit Singh
    Marko Fiege
    Frank Wappler
    Jochen Schulte am Esch
    Jens Scholz
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2002, 366 : 372 - 375
  • [4] Evidence for a spontaneous C1840-T mutation in the RYR1 gene after DNA fingerprinting in a malignant hyperthermia susceptible family
    Steinfath, M
    Seranski, P
    Singh, S
    Fiege, M
    Wappler, F
    Esch, JSA
    Scholz, J
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 366 (04) : 372 - 375
  • [5] Spontaneous C1840-T mutation in the RYR 1 gene in a malignant hyperthermia susceptible family
    Steinfath, M
    Buxmann, I
    Scholz, J
    Wappler, F
    Esch, JSA
    Singh, S
    ANESTHESIOLOGY, 1997, 87 (03) : A339 - A339
  • [6] A study of a family with the skeletal muscle RYR1 mutation (c.7354C>T) associated with central core myopathy and malignant hyperthermia susceptibility
    Taylor, A.
    Lachlan, K.
    Manners, R. M.
    Lotery, A. J.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2012, 19 (01) : 65 - 70
  • [8] DISCORDANCE, IN A MALIGNANT HYPERTHERMIA PEDIGREE, BETWEEN IN-VITRO CONTRACTURE-TEST PHENOTYPES AND HAPLOTYPES FOR THE MHS1 REGION ON CHROMOSOME 19Q12-13.2, COMPRISING THE C1840T TRANSITION IN THE RYR1 GENE
    DEUFEL, T
    SUDBRAK, R
    FEIST, Y
    RUBSAM, B
    DUCHESNE, I
    SCHAFER, KL
    ROEWER, N
    GRIMM, T
    LEHMANNHORN, F
    HARTUNG, EJ
    MULLER, CR
    AMERICAN JOURNAL OF HUMAN GENETICS, 1995, 56 (06) : 1334 - 1342
  • [9] Incomplete co-segregation of the ryanodine receptor gene C487T mutation with malignant hyperthermia susceptibility in a large Australian pedigree.
    Taske, NL
    Cavanaugh, JA
    Milburn, PJ
    Foster, PS
    Denborough, MA
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A297 - A297